These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 27866948)

  • 61. Aspirin as Thromboprophylaxis in Hip and Knee Arthroplasty: A Systematic Review and Meta-Analysis.
    An VV; Phan K; Levy YD; Bruce WJ
    J Arthroplasty; 2016 Nov; 31(11):2608-2616. PubMed ID: 27178011
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Aspirin monotherapy is a suitable standard thromboprophylactic agent following total hip arthroplasty.
    Borton ZM; Bhangoo NS; Quah CS; Stephen AB; Howard PW
    Hip Int; 2022 May; 32(3):286-290. PubMed ID: 33601921
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clinical experience with ximelagatran in orthopaedic surgery.
    Eriksson B
    Drugs; 2004; 64 Suppl 1():27-35. PubMed ID: 15586625
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Thromboprophylaxis for trauma patients.
    Barrera LM; Perel P; Ker K; Cirocchi R; Farinella E; Morales Uribe CH
    Cochrane Database Syst Rev; 2013 Mar; (3):CD008303. PubMed ID: 23543562
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Venous thromboembolism prophylaxis after hospital discharge: transition to preventive care.
    Kaatz S; Spyropoulos AC
    Hosp Pract (1995); 2011 Aug; 39(3):7-15. PubMed ID: 21881387
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty: a randomized trial.
    Anderson DR; Dunbar MJ; Bohm ER; Belzile E; Kahn SR; Zukor D; Fisher W; Gofton W; Gross P; Pelet S; Crowther M; MacDonald S; Kim P; Pleasance S; Davis N; Andreou P; Wells P; Kovacs M; Rodger MA; Ramsay T; Carrier M; Vendittoli PA
    Ann Intern Med; 2013 Jun; 158(11):800-6. PubMed ID: 23732713
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Oral direct factor Xa inhibitor versus enoxaparin for thromboprophylaxis after hip or knee arthroplasty: Systemic review, traditional meta-analysis, dose-response meta-analysis and network meta-analysis.
    Feng W; Wu K; Liu Z; Kong G; Deng Z; Chen S; Wu Y; Chen M; Liu S; Wang H
    Thromb Res; 2015 Dec; 136(6):1133-44. PubMed ID: 26498222
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The Role of Intraoperative Intermittent Pneumatic Compression Devices in Venous Thromboembolism Prophylaxis in Total Hip and Total Knee Arthroplasty.
    Tyagi V; Tomaszewski P; Lukasiewicz A; Theriault S; Pelker R
    Orthopedics; 2018 Jan; 41(1):e98-e103. PubMed ID: 29156069
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Are factor Xa inhibitors effective thromboprophylaxis following hip fracture surgery?: A large national database study.
    Campbell ST; Bala A; Jiang SY; Gardner MJ; Bishop JA
    Injury; 2017 Dec; 48(12):2768-2772. PubMed ID: 29102371
    [TBL] [Abstract][Full Text] [Related]  

  • 70. American Association of Orthopedic Surgeons and American College of Chest Physicians guidelines for venous thromboembolism prevention in hip and knee arthroplasty differ: what are the implications for clinicians and patients?
    Eikelboom JW; Karthikeyan G; Fagel N; Hirsh J
    Chest; 2009 Feb; 135(2):513-520. PubMed ID: 19201714
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Post-operative arterial thrombosis with non-vitamin K antagonist oral anticoagulants after total hip or knee arthroplasty.
    Squizzato A; Lussana F; Cattaneo M
    Thromb Haemost; 2015 Aug; 114(2):237-44. PubMed ID: 25946985
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Meta-analysis of thromboembolic prophylaxis after total knee arthroplasty.
    Westrich GH; Haas SB; Mosca P; Peterson M
    J Bone Joint Surg Br; 2000 Aug; 82(6):795-800. PubMed ID: 10990299
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
    Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
    Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The role of apixaban for venous and arterial thromboembolic disease.
    Prom R; Spinler SA
    Ann Pharmacother; 2011 Oct; 45(10):1262-83. PubMed ID: 21954450
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Meta-analysis of cause of death following total joint replacement using different thromboprophylaxis regimens.
    Poultsides LA; Gonzalez Della Valle A; Memtsoudis SG; Ma Y; Roberts T; Sharrock N; Salvati E
    J Bone Joint Surg Br; 2012 Jan; 94(1):113-21. PubMed ID: 22219258
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effect of oral factor Xa inhibitor and low-molecular-weight heparin on surgical complications following total hip arthroplasty.
    Kim SM; Moon YW; Lim SJ; Kim DW; Park YS
    Thromb Haemost; 2016 Mar; 115(3):600-7. PubMed ID: 26790579
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Timing of Symptomatic Pulmonary Embolism with Warfarin Following Arthroplasty.
    Parvizi J; Huang R; Raphael IJ; Maltenfort MG; Arnold WV; Rothman RH
    J Arthroplasty; 2015 Jun; 30(6):1050-3. PubMed ID: 25648058
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The incidence of fatal pulmonary embolism after primary hip and knee replacement in a consecutive series of 4253 patients.
    Cusick LA; Beverland DE
    J Bone Joint Surg Br; 2009 May; 91(5):645-8. PubMed ID: 19407300
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prophylaxis against venous thromboembolism in orthopedic surgery.
    Liu LT; Ma BT
    Chin J Traumatol; 2006 Aug; 9(4):249-56. PubMed ID: 16849000
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Extended Anticoagulant and Aspirin Treatment for the Secondary Prevention of Thromboembolic Disease: A Systematic Review and Meta-Analysis.
    Marik PE; Cavallazzi R
    PLoS One; 2015; 10(11):e0143252. PubMed ID: 26587983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.